|
Gonik et al. (2000) [19]
|
USA
|
313/43% Obstetrician-gynecologists
|
Assess routinely the patients for vaccine- preventable diseases
|
Reported habit to administer vaccines
|
Spearman rho correlation 0.30–0.70; p < 0.05
|
None
|
|
Zimmerman et al. (2002) [22]
|
USA
|
281/72,4% general practitioners, family practice, pediatricians
|
Agreement with the national recommendations on varicella vaccination. Yes vs no
|
Would recommend the vaccination
|
In children 12–18 months: 98%
|
1A,1C, 1D,3E, 1F
|
|
vs 3%, p < 0.05
|
|
Children 4–6 years: 93%
|
|
vs 19%, p < 0.05
|
|
Children 11–12 years:
|
|
86% vs 68%, p < 0.05
|
|
Taylor et al. (2002) [21]
|
USA
|
112/? pediatricians
|
A) Number of injections willing to give in one visit. Range 1 to 6 (>5)
|
Increase of record linked vaccine coverage
|
A) Per each injection more: Increase at 8 months of 3.6% (95% CI 0.4-6.8) p > 0.05, at 19 months 1.5% (95% CI −2.8 - 5.5) p > 0.05
|
2B, 1C, 3E
|
|
B) Recommendation of inactivated polio vaccine (IPV) vs oral vaccine
|
B) Using IPV: Increase at 8 months of 8.9% (95% CI 3.3-15.4) p < 0.05, at 19 months 15.4% (95% CI 7.7 - 23.1) p < 0.05
|
|
Schupfner et al. (2002) [20]
|
Germany
|
97/73% pediatricians
|
Prefer to give combined vaccines than separate
|
Reported vaccine coverage rate
|
100% in those with high reported coverage (>80%) vs 81% in low coverage (<80%) p > 0.05
|
2C,4D,4E
|
|
Milledge et al. (2003) [24]
|
Australia
|
160/67% general practitioners
|
Concerns about varicella vaccine: A) Immunity may not be life-long
|
Would recommend universal varicella vaccination
|
A) OR 0.60 (95%CI 0.33-1.21) p > 0.05
|
1B, 1C, 7E, 2F
|
|
B) Increase in herpes zoster
|
B) OR 1.08 (0.33-3.6) p > 0.05
|
|
C) More serious varicella disease in adults
|
C) OR 0.92 (0.37-2.27) p > 0.05
|
|
D) Possible, unknown side effects
|
D) OR: 0.31 (0.15–0.63) p > 0.05
|
|
Davis et al. (2003) [23]
|
USA
|
694/60% family physicians
|
A) Considers giving 5 injections at 1 visit vs less
|
Reported habit of recommending the vaccine
|
A) OR 17.29 (95% CI 6.35, 47.05) p < 0.05
|
4E, 1F
|
|
B) Considers giving 4 injections at 1 visit vs less
|
B) OR 8.69(95% CI 4.21, 17.94) p < 0.05
|
|
Jungbauer-Gans et al. (2003) [25]
|
Germany
|
136/71% family physicians and pediatricians
|
Importance of the officially recommended vaccinations (Index: 1 = not at all, 5 = very)
|
Reported habit of recommending full vaccination
|
Index of 4.8 in those recommending full vaccination vs 3.9 in those who did not. p < 0.05
|
None
|
| | |
94/71% family physicians and pediatricians
|
Importance of the officially recommended vaccinations (same Index)
|
Record linked vaccine coverage
|
One point increase in the Index was associated with an increase of 25.8% in the coverage. p < 0.05
|
None
|
|
Wilson et al. (2004) [26]
|
Canada
|
312/59,4% naturopathic students
|
Trust in Public Health information
|
Willingness to advise full vaccination
|
OR 3.72 (95% CI 1.42–10.7) p < 0.05
|
1D, 5E
|
|
Clark et al. (2006) [29]
|
USA
|
183/54% obstetricians
|
Perceive to have a role in promote Tdap vaccination to other adults (not mothers) in contact with infants
|
Report to recommend Tdap vaccine to pregnant women
|
77% perceive having a role in those recommending vaccine to pregnant women vs 50% in those who do not. p < 0.05
|
None
|
|
Davis et al. (2007) [30]
|
USA
|
336/49% family physicians, general internists
|
Agree that pertoussis is serious enough to warrant using Tdap in adults. Yes vs no or neutral
|
Would recommend the vaccination if recommended
|
93% vs 68%. p < 0.05
|
None
|
|
Gust et al. (2008) [31]
|
USA
|
733/65% family physicians, pediatricians
|
Have some concerns about immunization
|
Recommend full immunization
|
OR 0.32 (95% CI 0.56-0.19) p < 0.05
|
1C, 1D, 1E
|
